Johnson & Johnson has entered into a research partnership with the Mercy health system to utilise real-world data to evaluate medical device performance.
data
Mercy has developed a data platform that evaluates medical device performance to ensure those devices work for patients.
Dr Joseph Drozda, Mercy's director of outcomes research said: “We began this project to make sure the devices Mercy uses work for patients. With more than 8,000 new medical devices entering the market each year, it's critical that we find better ways to evaluate their performance."
Johnson & Johnson’s medical device division will utilise data from Mercy to inform and improve regulatory decision making and health outcomes for medical devices.
Dr Drozda states that the FDA is now beginning to encourage the use of real-world data to evaluate medical devices.
"Not only does Mercy have diverse data, we have the data platform, quality, scale and sophisticated data scientists to turn this data into meaningful information. That's critical where patient outcomes are concerned," said Dr. Drozda.